Apceth Biopharma GmbH, a company with the mission of improving patients’ lives with next generation cell therapies, announced today positive results for?apceth-201?in mouse models for acute graft-versus-host disease (aGvHD). The data was highlighted in a
Apceth Biopharma GmbH, a company with the mission of improving patients’ lives with next generation cell therapies, announced today positive results for?apceth-201?in mouse models for acute graft-versus-host disease (aGvHD). The data was highlighted in a